ADMA Biologics Inc vs Cincinnati Financial Corporation — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Cincinnati Financial Corporation trades at $173.45 (market cap $26.58B). The key difference: Cincinnati Financial Corporation is far larger — about 12× ADMA Biologics Inc's market cap, and Cincinnati Financial Corporation pays a 2.17% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | CINF | |
|---|---|---|
Market Cap | $2.22B | $26.58B |
Sector | Health | Financials |
52-Week High | $20.38 | $192.03 |
52-Week Low | $7.60 | $149.79 |
Enterprise Value | $2.29B | $25.71B |
Dividend Yield | — | 2.17% |
Trailing returns across standard periods
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.
Read more on CINF →